ABT
Abbott Laboratories
- Diluted EPS, 2025
- $3.72
- YoY, 2025
- −51.3%
- 5-year CAGR
- +8.3%
- 10-year CAGR
- +2.5%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $3.72 | −51.3% |
| 2024 | $7.64 | +134.4% |
| 2023 | $3.26 | −16.6% |
| 2022 | $3.91 | −0.8% |
| 2021 | $3.94 | +57.6% |
| 2020 | $2.50 | +21.4% |
| 2019 | $2.06 | +54.9% |
| 2018 | $1.33 | +392.6% |
| 2017 | $0.27 | −71.3% |
| 2016 | $0.94 | −67.8% |
| 2015 | $2.92 | +96.0% |
| 2014 | $1.49 | −8.0% |
| 2013 | $1.62 | −56.5% |
| 2012 | $3.72 | +23.6% |
| 2011 | $3.01 | +1.7% |
| 2010 | $2.96 | −19.8% |
| 2009 | $3.69 | +18.3% |
| 2008 | $3.12 | +35.1% |
| 2007 | $2.31 | — |